(lp0
S'Infinity Pharmaceuticals Inc versus Osiris Therapeutics Inc Head to Head Compare CML News - Aug 23, 2016 Osiris Therapeutics Inc has a substantially higher fundamental rating then Infinity Pharmaceuticals Inc which has an impact on the head-to-head comparison.'
p1
aS'Infinity Pharmaceuticals Inc.  Soars 19.02% on April 17 Equities.com - 12 hours ago Infinity Pharmaceuticals Inc.  had a good day on the market for Monday April 17 as shares jumped 19.02% to close at $2.19.Unusual Activity Sighted in Infinity Pharmaceuticals, Inc.  Shares - The HeraldInfinity Pharmaceuticals, Inc.  has industry P/E ratio of 51.72 - The Newburgh Press'
p2
aS"Infinity Pharmaceuticals, Inc. : The Technicals As Seen Today NY Stock News - 17 hours ago Infinity Pharmaceuticals, Inc.  has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment."
p3
aS"Analyst's Predictions on Infinity Pharmaceuticals, Inc. , Delcath ... StockNewsJournal - 20 hours ago Infinity Pharmaceuticals, Inc.  have shown a high EPS growth of 16.60% in the last 5 years and has earnings decline of 76.80% yoy."
p4
aS'Infinity Pharmaceuticals Inc.  Plunges 5.84% on April 07 Equities.com - Apr 7, 2017 Infinity Pharmaceuticals Inc.  had a rough trading day for Friday April 07 as shares tumbled 5.84%, or a loss of $-0.15 per share, to close at $2.42.Noteworthy Price Swings: Infinity Pharmaceuticals, Inc.  - StandardOracleTraders Secrets on DSW Inc. , Infinity Pharmaceuticals, Inc.  - StockNewsJournal'
p5
aS'Ticker Scope: Watching Shares of Infinity Pharmaceuticals, Inc.  Benton Bulletin - 10 hours ago Infinity Pharmaceuticals, Inc.  presently has a Piotroski F-Score of 3. The goal of the F-Score is to help locate companies with strengthening balance sheets, and to weed out poor performers.'
p6
aS'Infinity Pharmaceuticals Inc.  Plunges 7.62% on April 12 Equities.com - Apr 12, 2017 Infinity Pharmaceuticals Inc.  had a rough trading day for Wednesday April 12 as shares tumbled 7.62%, or a loss of $-0.16 per share, to close at $1.94.Prominent Runner: Infinity Pharmaceuticals, Inc.  - StandardOracleInfinity Pharmaceuticals Focuses on Lead Candidate IPI-549 - Yahoo Finance'
p7
aS'Infinity Pharmaceuticals Inc.  Plunges 5.15% on April 14 Equities.com - Apr 14, 2017 Infinity Pharmaceuticals Inc.  had a rough trading day for Friday April 14 as shares tumbled 5.15%, or a loss of $-0.1 per share, to close at $1.84.Stock under Review: Infinity Pharmaceuticals Inc.  - Post RegistrarMarket: The Infinity Pharmaceuticals, Inc.  Receives $1.50 Consensus ... - Petro Global News 24'
p8
aS'Infinity Pharmaceuticals Inc.  Moves Lower on Volume Spike for April 13 Equities.com - Apr 13, 2017 Infinity Pharmaceuticals Inc.  traded on unusually high volume on Apr. 13, as the stock lost 5.15% to close at $1.84.Infinity Pharmaceuticals Inc.  Down 11 Days in a Row? - StockNewsUnion'
p9
aS"3 Reasons Why Infinity Pharmaceuticals  is a Great Momentum Stock Yahoo Finance - Mar 23, 2017 This method discovered several great candidates for momentum-oriented investors, but today let's focus in on Infinity Pharmaceuticals, Inc. INFI as this stock is looking especially impressive right now. And while there are numerous ways in which this ...Infinity Pharma Focuses on Cancer Drug: Competition Looms - Zacks.comBuy or Sell? Average Brokerage Ratings on Spectrum Pharmaceuticals, Inc. (SPPI ... - StockNewsJournal"
p10
a.